Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism

被引:25
作者
Modeste Alexandre Yahouedehou, Setondji Cocou [1 ,2 ]
Adorno, Elisangela Vitoria [2 ]
da Guarda, Caroline Conceicao [1 ]
Ndidi, Uche Samuel [1 ]
Carvalho, Suellen Pinheiro [1 ,2 ]
Santiago, Rayra Pereira [1 ]
Aleluia, Milena Magalhaes [1 ]
de Oliveira, Rodrigo Mota [1 ,2 ]
Goncalves, Marilda de Souza [1 ,2 ]
机构
[1] Fiocruz MS, IGM, LIGHT, Salvador, BA, Brazil
[2] Univ Fed Bahia, Fac Farm, LPA, Dept Anal Clin, Salvador, BA, Brazil
关键词
FETAL-HEMOGLOBIN RESPONSE; BETA-THALASSEMIA; NITRIC-OXIDE; PROMOTER POLYMORPHISMS; GENE-EXPRESSION; BILIRUBIN RESPONSE; ANEMIA PATIENTS; KLF10; GENE; THERAPY; TRANSPORTER;
D O I
10.1038/s41397-018-0045-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hydroxyurea (HU) was approved to be used in the treatment of sickle cell disease (SCD) because of its anti-sickling potential. However, there is variability in HU response among SCD patients and this can be due to physiological, socioeconomic, environmental, metabolic and/or genetic factors. The present review focuses on the latter two. Three quantitative trait loci, HBG2, BCL11A and HMIP, have been suggested as important markers for HU response. Other genes (ASS1, KLF10, HAO2, MAP3K5, PDE7B, TOX, NOS1, NOS2A, FLT1, ARG1, ARG2, UGT1A1, OR51B5/6, SIN3A, SALL2, SAR1A, UTB, OCTN1, CYP2C9, AQP9, MPO, CYP2E1, and GSTT1) have also been considered. Studies implicate catalase, urease, horseradish peroxidase and enzymes of CYP450 family in HU metabolism. However, little is known about these enzymes. Therefore, further studies are needed to elucidate the metabolic pathway of HU, which will facilitate pharmacogenomic studies and help in identification of candidate genes for predicting HU response.
引用
收藏
页码:730 / 739
页数:10
相关论文
共 66 条
[1]  
ADAMSON RH, 1965, J PHARMACOL EXP THER, V150, P322
[2]   The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, βS-globin gene haplotype, co-inherited α-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia [J].
Adekile, A ;
Kutlar, F ;
McKie, K ;
Addington, A ;
Elam, D ;
Holley, L ;
Clair, B ;
Kutlar, A .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (02) :150-155
[3]   Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels [J].
Adekile, Adekunle ;
Menzel, Stephan ;
Gupta, Renu ;
Al-Sharida, Sondus ;
Azab, Asmaa Farag ;
Haider, Mohammad ;
Akbulut, Nagihan ;
Mustafa, Nada ;
Thein, Swee Lay .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) :E138-E139
[4]   Fetal hemoglobin in sickle cell anemia: Molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans [J].
Akinsheye, Idowu ;
Solovieff, Nadia ;
Duyen Ngo ;
Malek, Anita ;
Sebastiani, Paola ;
Steinberg, Martin H. ;
Chui, David H. K. .
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) :217-219
[5]   Hydroxyurea in the treatment of major β-thalassemia and importance of genetic screening [J].
Alebouyeh, M ;
Moussavi, F ;
Haddad-Deylami, H ;
Vossough, P .
ANNALS OF HEMATOLOGY, 2004, 83 (07) :430-433
[6]   Genetic modulation of fetal hemoglobin in hydroxyurea-treated sickle cell anemia [J].
Aleluia, Milena Magalhaes ;
Santiago, Rayra Pereira ;
da Guarda, Caroline Conceicao ;
Cardoso Fonseca, Teresa Cristina ;
Neves, Fabia Idalina ;
Quinto, Regiana Souza ;
Boas Figueiredo, Camylla Villas ;
Modeste Alexandre Yahouedehou, Setondji Cocou ;
Oliveira, Rodrigo Mota ;
Dutra Ferreira, Junia Raquel ;
Veloso Cerqueira, Bruno Antonio ;
Barbosa, Cynara Gomes ;
Milton, Jacqueline Nicole ;
Steinberg, Martin H. ;
Goncalves, Marilda de Souza .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (05) :E70-E72
[7]  
Ali Nadir, 2015, Hematol Oncol Stem Cell Ther, V8, P10, DOI 10.1016/j.hemonc.2014.12.004
[8]   EVIDENCE FOR THE INVOLVEMENT OF CYTOCHROME-P-450-DEPENDENT MONOOXYGENASE(S) IN THE FORMATION OF GENOTOXIC METABOLITES FROM N-HYDROXYUREA [J].
ANDRAE, U .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 118 (02) :409-415
[9]   Role of Kruppel-like transcription factors in endothelial biology [J].
Atkins, G. Brandon ;
Jain, Mukesh K. .
CIRCULATION RESEARCH, 2007, 100 (12) :1686-1695
[10]   Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? [J].
Banan, Mehdi .
ANNALS OF HEMATOLOGY, 2013, 92 (03) :289-299